We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$834M
2
FDX icon
FedEx
FDX
+$666M
3
MSFT icon
Microsoft
MSFT
+$594M
4
AMD icon
Advanced Micro Devices
AMD
+$585M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$403M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CD
11576
PUT
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$173K ﹤0.01%
+20,600
New +$242K
AAIC
11577
CALL
DELISTED
Arlington Asset Investment Corp.
AAIC
$173K ﹤0.01%
46,700
-32,400
-41% -$123K
DBTX
11578
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$173K ﹤0.01%
+22,426
New +$171K
YVR
11579
CALL
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$173K ﹤0.01%
27,175
+9,875
+57% +$68.7K
SIFY
11580
PUT
Sify Technologies
SIFY
$1.07B
$172K ﹤0.01%
8,483
-650
-7% -$13.5K
TZOO icon
11581
CALL
Travelzoo
TZOO
$67.9M
$172K ﹤0.01%
+14,800
New +$188K
MTVA
11582
PUT
MetaVia Inc
MTVA
$10.9M
$172K ﹤0.01%
18
+1
+6% +$9.43K
NAGE
11583
PUT
Niagen Bioscience
NAGE
$254M
$172K ﹤0.01%
27,500
-10,200
-27% -$84.1K
GAMCU
11584
DELISTED
Golden Arrow Merger Corp. Unit
GAMCU
$172K ﹤0.01%
17,338
-533
-3% -$5.29K
CRBP icon
11585
CALL
Corbus Pharmaceuticals
CRBP
$215M
$171K ﹤0.01%
5,577
-3,686
-40% -$145K
CSTE icon
11586
Caesarstone
CSTE
$111M
$171K ﹤0.01%
13,795
-101,724
-88% -$1.37M
CULP icon
11587
PUT
Culp Inc
CULP
$43.6M
$171K ﹤0.01%
13,300
-77,600
-85% -$1.09M
CBIO
11588
CALL
Crescent Biopharma
CBIO
$660M
$171K ﹤0.01%
779
-692
-47% -$147K
MLP icon
11589
Maui Land & Pineapple Co
MLP
$315M
$171K ﹤0.01%
+16,496
New +$176K
MPX
11590
PUT
DELISTED
Marine Products Corp
MPX
$171K ﹤0.01%
+13,700
New +$200K
NMRD
11591
CALL
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$171K ﹤0.01%
28,400
-30,700
-52% -$221K
EMKR
11592
DELISTED
Emcore Corp
EMKR
$171K ﹤0.01%
2,284
-4,358
-66% -$348K
ARKO icon
11593
ARKO Corp
ARKO
$500M
$170K ﹤0.01%
+16,822
New +$152K
CYCN icon
11594
Cyclerion Therapeutics
CYCN
$18.7M
$170K ﹤0.01%
2,766
-1,243
-31% -$81.3K
DMAC icon
11595
PUT
DiaMedica Therapeutics
DMAC
$364M
$170K ﹤0.01%
42,400
-4,800
-10% -$18.4K
HBIO icon
11596
Harvard Bioscience
HBIO
$36M
$170K ﹤0.01%
2,442
+96
+4% +$7.64K
HRTX icon
11597
CALL
Heron Therapeutics
HRTX
$63M
$170K ﹤0.01%
+15,900
New +$194K
KTF
11598
DWS Municipal Income Trust
KTF
$344M
$170K ﹤0.01%
+14,264
New +$175K
RES icon
11599
CALL
RPC Inc
RES
$1.42B
$170K ﹤0.01%
34,900
-53,600
-61% -$224K
NAGE
11600
Niagen Bioscience
NAGE
$254M
$170K ﹤0.01%
27,040
-66,479
-71% -$548K
462 463
464
465 466

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.